Aldosterone Levels in Obese Women with or without Hypertension

Autor:	Mehmet Tüzün, Candeger Yilmaz, P. Taskın, Fulden Sarac, Gokhan Ozgen, Fusun Saygili
Přispěvatelé:	Ege Üniversitesi
Rok vydání:	2006
Předmět:	medicine.medical_specialty Aldosterone business.industry Group ii Furosemide Aldosterone levels Plasma levels chemistry.chemical_compound Endocrinology chemistry Internal medicine medicine business Normal range Biotechnology Plasma aldosterone level medicine.drug
Zdroj:	Biotechnology & Biotechnological Equipment. 20:123-127
ISSN:	1314-3530 1310-2818
DOI:	10.1080/13102818.2006.10817317
Popis:	In this study, our objective was to evaluate aldosterone levels after administration of furosemide and angiotensin-converting enzyme (ACE) inhibiting drugs in hypertensive and normotensive obese women. 40 normotensive (group I) and 40 hypertensive obese women (group II) were included in the study. Mean plasma aldosterone level changed from 9.45±2.60 ng/dl to 8.85±2.70 ng/dl after administration of furosemide in group I patients. In the same group, mean aldosterone level changed from 9.175±2.89 ng/dl to 8.75±2.70 ng/dl after administration of captoprile. In hypertensive obese women, mean plasma aldosterone level changed from 11.60±3.69 ng/dl to 9.60±2.90 ng/dl (P=0.04) after administration of furosemide. In the same group mean aldosterone level changed from 13.30±3.30 ng/dl to 12.85±3.67 ng/dl after captoprile administration. Despite normal range of aldosteron levels at baseline, hypertensive obese patients had higher plasma levels. © 2006 Taylor and Francis Group, LLC.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f388821ae78f6824f14c740653549be7 https://doi.org/10.1080/13102818.2006.10817317 Zobrazit plný text záznamu